Five fast lessons from Reuters Pharma USA 2025
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
1 min read
Emilie Branch
Sep 21, 2022 6:17:00 PM
By: Emilie Branch, Content Manager, Swoop
Building custom audience segments can help marketers better reach consumers.
Katie Carr, SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr delves into the privacy changes being made by branded technology walled gardens and why strengthening targeting via a custom-built patient audience segment puts advertisers in a more favorable position as those shifts occur.
Content Manager
![]()
|
Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.
|
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
Is it possible to truly move from sick care to health care? This year at Reuters Pharma USA, Co-founder and President of MyHealthTeam and Chief...
Traditional marketing strategies utilized by retail brands and airlines often don’t work for pharmaceutical manufacturers. Unlike other categories,...